Vipul Joshi, MD
Rheumatology · Brandon, FLNPI 1003868993
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $25,844 of the $42,600 with a category attached, or 60.7%. 37 manufacturers reported payments, led by Amgen at 47.0% of the total. Reporting peaked in 2019 at $16,530 and has fallen 72.3% since, to $4,573 in 2025.
Across 1,500 payments — averaging $28.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$20K
- UCB, Inc.$4K
- Novartis$3K
- AbbVie$2K
- AstraZeneca$2K
- Merck$1K
- plus $10K from 31 others
Across 485 payments — averaging $6322.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$696K
- AbbVie$523K
- Novartis$455K
- Astrazeneca UK Limited$357K
- GSK$325K
- UCB SA$284K
- plus $426K from 10 others
What the payments were for
- Consulting fees$9,67523%
- Speaking & faculty fees$2,7006%
- Travel & lodging$4,18010%
- Food & beverage$25,84461%
- Education$2010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 438 | $20,036 |
| UCB, Inc. | 190 | $3,969 |
| Novartis | 104 | $3,060 |
| AbbVie | 112 | $2,282 |
| AstraZeneca(2 entities) | 73 | $1,670 |
| Merck | 8 | $1,430 |
| Astrazeneca UK Limited | 9 | $1,246 |
| Genentech USA, Inc. | 89 | $1,225 |
| GSK | 67 | $1,071 |
| Pfizer | 76 | $1,042 |
| Johnson & Johnson | 57 | $1,021 |
| E.r. Squibb & Sons, L.L.C. | 79 | $996 |
| Radius Health, Inc. | 52 | $860 |
| Mallinckrodt Hospital Products Inc. | 29 | $584 |
| Aurinia Pharma U.S., Inc. | 19 | $379 |
| ANI Pharmaceuticals, Inc. | 17 | $334 |
| Lilly USA, LLC | 17 | $327 |
| Sanofi | 12 | $236 |
| Boehringer Ingelheim | 6 | $137 |
| Bristol Myers Squibb | 11 | $122 |
| Sandoz | 4 | $64 |
| Sanofi-aventis U.S. LLC | 4 | $61 |
| Mallinckrodt Enterprises LLC | 3 | $55 |
| Medexus Pharma, Inc. | 4 | $47 |
| Scilex Pharmaceuticals Inc. | 2 | $42 |
| Fresenius Kabi USA, LLC | 2 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $39 |
| Sobi, Inc | 2 | $36 |
| Zimmer Biomet | 1 | $32 |
| Fidia Pharma USA Inc. | 4 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Bioventus LLC | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Sebela Pharmaceuticals Inc. | 1 | $18 |
| Organon | 1 | $16 |
| Tersera Therapeutics LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,600 in reported general payments places this provider in the 85th percentile of 453 rheumatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 17 | $156,596 |
| Humira PenAdalimumab | 15 | $118,543 |
| Pregabalin | 122 | $4,015 |
| Tramadol Hcl | 284 | $2,273 |
| Hydroxychloroquine Sulfate | 23 | $1,209 |
| MethotrexateMethotrexate Sodium | 13 | $273 |
| Duloxetine Hcl | 13 | $170 |
| Clonazepam | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Brandon
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Jigar ShahMargate$750K
- Rachel TateHollywood$729K
- Howard BuschLoxahatchee$717K
- Michael WeitzMiami$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.